Why An AI Biotech Startup Launched A $600 Million Fund To Buy Stalled Drugs

Formation Bio, an AI-driven biotech startup, has launched a $600 million fund to acquire or license drug candidates stalled in clinical trials, aiming to address bottlenecks in drug development beyond discovery.